Johnson & Johnson CEO Joaquin Duato’s total compensation was about $32 million in 2027, according to a Securities and Exchange Commission proxy filing.
The company’s March 11 filing revealed the compensation packages for five executives from 2023 to 2025. Compensation packages include salary, stock and option awards, non-equity incentive plan compensation and other forms of pay.
Joaquin Duato, chair and CEO
2025: $32.7 million
2024: $24.3 million
2023: $28.4 million
Joseph Wolk, executive vice president and CFO
2025: $14.4 million
2024: $12.6 million
2023: $14 million
Tim Schmid, executive vice president, worldwide chair of innovative medicine
2025: $9.3 million
2024: $11.9 million
Jennifer Taubert, executive vice president and worldwide chair of pharmaceuticals
2025: $14 million
2024: $11.2 million
2023: $11 million
John Reed, MD, PhD, executive vice president of innovative medicine and research and development
2025: $12.2 million
2024: $9.3 million
2023: $20.6 million
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
